Literature DB >> 19683859

A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature.

Alexander Roosen1, Christopher R Chapple, Roger R Dmochowski, Clare J Fowler, Christian Gratzke, Claus G Roehrborn, Christian G Stief, Karl-Erik Andersson.   

Abstract

CONTEXT: The focus of clinical understanding and management of male storage lower urinary tract symptoms (LUTS) has shifted from the prostate to the bladder. This is mirrored by an increasing body of experimental evidence suggesting that the bladder is the central organ in the pathogenesis of LUTS.
OBJECTIVE: A systematic review of the literature available on pathophysiologic aspects of storage LUTS. EVIDENCE ACQUISITION: Medline was searched for the period ending December 2008 for studies on human and animal tissue exploring possible functional and structural alterations underlying bladder dysfunction. Further studies were chosen on the basis of manual searches of reference lists and review papers. EVIDENCE SYNTHESIS: Numerous recent publications on LUTS pathophysiology were identified. They were grouped into studies exploring abnormalities on urothelial/suburothelial, muscular, or central levels.
CONCLUSIONS: Studies revealed both structural and functional alterations in bladders from patients with LUTS symptoms or animals with experimentally induced bladder dysfunction. In particular, the urothelium and the suburothelial space, containing afferent nerve fibres and interstitial cells, have been found to form a functional unit that is essential in the process of bladder function. Various imbalances within this suburothelial complex have been identified as significant contributors to the generation of storage LUTS, along with potential abnormalities of central function.

Entities:  

Mesh:

Year:  2009        PMID: 19683859     DOI: 10.1016/j.eururo.2009.07.044

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  41 in total

Review 1.  The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.

Authors:  Karl-Erik Andersson; Donna B Boedtkjer; Axel Forman
Journal:  Ther Adv Urol       Date:  2016-11-04

Review 2.  Neuropsychiatric disorders and voiding problems in children.

Authors:  Israel Franco
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

3.  [Treatment for overactive bladder].

Authors:  P Rothe; M Kalchthaler; S Mühlich
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

Review 4.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

5.  Intakes of vitamins and minerals in relation to urinary incontinence, voiding, and storage symptoms in women: a cross-sectional analysis from the Boston Area Community Health survey.

Authors:  Nancy N Maserejian; Edward L Giovannucci; Kevin T McVary; John B McKinlay
Journal:  Eur Urol       Date:  2011-03-15       Impact factor: 20.096

6.  Urinary bladder organ hypertrophy is partially regulated by Akt1-mediated protein synthesis pathway.

Authors:  Li-Ya Qiao; Chunmei Xia; Shanwei Shen; Seong Ho Lee; Paul H Ratz; Matthew O Fraser; Amy Miner; John E Speich; Jeffrey J Lysiak; William D Steers
Journal:  Life Sci       Date:  2018-03-21       Impact factor: 5.037

7.  Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?

Authors:  Cees Korstanje; Walter Krauwinkel; Francisca L C van Doesum-Wolters
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

8.  Dietary macronutrient and energy intake and urinary incontinence in women.

Authors:  Nancy N Maserejian; Edward L Giovannucci; Kevin T McVary; Catherine McGrother; John B McKinlay
Journal:  Am J Epidemiol       Date:  2010-04-25       Impact factor: 4.897

Review 9.  β3-receptor agonists for overactive bladder--new frontier or more of the same?

Authors:  Karl-Erik Andersson
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

10.  Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostate.

Authors:  Stefan Ückert; Eginhard S Waldkirch; Axel S Merseburger; Markus A Kuczyk; Matthias Oelke; Petter Hedlund
Journal:  World J Urol       Date:  2013-03-09       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.